PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility

Carcinogenesis

Volumn 28, Issue 5, 2007, Pages 1032-1039

  Lai, John ^a   Kedda, Mary Anne ^a   Hinze, Kimberly ^a   Smith, Robert L G ^a   Yaxley, John ^b   Spurdle, Amanda B ^c   Morris, C Phillip ^a   Harris, Jonathan ^a   Clements, Judith A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b Mater Private Hospital Brisbane   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANDROGEN; ANDROGEN RECEPTOR; GUANINE; PROSTATE SPECIFIC ANTIGEN; AR PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE CONTROL; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HIGH RISK POPULATION; HORMONE RESPONSE; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RECEPTOR BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; ADOLESCENT; CASE CONTROL STUDY; CHEMICAL STRUCTURE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PROSTATE TUMOR; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, MOLECULAR; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RISK FACTORS;

EID: 34447104185     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl236     Document Type: Article

References (30)

1. Clements, J.A. (1989) The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr. Rev., 10, 393-419.
2. Yousef, G.M. et al. (2000) Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun., 276, 125-133.
3. Sinha, A.A. et al. (1987) Immunoelectron microscopic localization of prostatic-specific antigen in human prostate by the protein A-gold complex. Cancer, 60, 1288-1293.
4. Nelson, C.C. et al. (1999) Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol. Endocrinol, 13, 2090-2107.
5. Cleutjens, K.B. et al. (1997) An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol 11, 148-161.
6. Cleutjens, K.B. et al. (1996) Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J. Biol. Chem., 271, 6379-6388.
7. Riegman, P.H. et al. (1991) The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol. Endocrinol, 5, 1921-1930.
8. Cramer, S.D. et al. (2003) Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J. Natl Cancer Inst., 95, 1044-1053.
9. Thompson, I. et al. (2003) Prostate cancer and prostate-specific antigen: The more we know, the less we understand. J. Natl Cancer Inst., 95, 1027-1028.
10. Rao, A. et al. (1999) Identification of a polymorphism in the ARE I region of the PSA promoter. Proc. Am. Assoc. Cancer Res., 40 60.
11. Schatzl, G. et al. (2005) Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer. Urology, 65, 1141-1145.
12. Xu, J. et al. (2002) Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes. Cancer Epidemiol. Biomarkers Prev., 11, 664-469.
13. Xue, W.M. et al. (2001) Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol. Biomarkers Prev., 10, 575-579.
14. Medeiros, R. et al. (2002) Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk. and circulating tumor cells. Prostate, 53, 88-94.
15. Rao, A. et al. (2003) Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms. Urology, 61, 864-869.
16. Xue, W. et al. (2000) Susceptibility to prostate cancer, interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res., 60, 839-841.
17. Cicek, M.S. et al. (2005) Role of androgen metabolism genes CYPIB1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness. Cancer Epidemiol. Biomarkers Prev., 14, 2173-2177.
18. Gsur, A. et al. (2002) Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis, 23, 1647-1651.
19. Binnie, M.C. et al. (2005) Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Prostate, 63, 309-315.
20. Chiang, C.H. et al. (2004) The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer. J. Urol., 171, 1529-1532.
21. Mononen, N. et al. (2006) Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors. Cancer Res., 66, 743-747.
22. Salinas, C.A. et al. (2005) Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate, 65, 58-65.
23. Wang, L.Z. et al. (2003) Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population. Cancer Lett., 202, 53-59.
24. Krieger, E. et al. (2004) Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins 57, 678-683.
25. Shaffer, P.L. et al. (2004) Structural basis of androgen receptor binding to selective androgen response elements. Proc. Natl Acad. Sci. USA, 101, 4758-4763.
26. Miller, S.A. et al. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
27. Liu, J. et al. (2003) Polymorphisms of prostate-specific antigen gene promoter: Determination from cord blood collected on filter paper. Ann. Clin. Lab. Sci., 33, 429-434.
28. Roche, P.J. et al. (1992) A consensus DNA-binding site for the androgen receptor. Mol. Endocrinol, 6, 2229-2235.
29. Geserick, C. et al. (2003) Differential modulation of androgen receptor action by deoxyribonucleic acid response elements. Mol. Endocrinol, 17, 1738-1750.
30. Sieh, W. et al. (2006) Genetic susceptibility to prostate cancer: prostate-specific antigen and its interaction with the androgen receptor (United States). Cancer Causes Control, 17, 187-97.